Please login to the form below

Not currently logged in
Email:
Password:

US

This page shows the latest US news and features for those working in and with pharma, biotech and healthcare.

Novartis forges AI alliance with Oxford University

Novartis forges AI alliance with Oxford University

Novartis' John Tsai. “Our work with the Big Data Institute will enable us to combine different types of data such as clinical, imaging and genomics, and use advanced analytical capabilities to

Latest news

  • Evenity back on track with FDA panel blessing in osteoporosis Evenity back on track with FDA panel blessing in osteoporosis

    Amgen and UCB’s long path to US approval of osteoporosis drug Evenity finally seems to be nearing an end, with an FDA panel voting in favour of the drug yesterday. ... Amgen has already secured its first marketing approval for Evenity (romosozumab) –

  • J&J’s Erleada cleared for early prostate cancer in Europe J&J’s Erleada cleared for early prostate cancer in Europe

    The new indication comes almost a year after Erleada was approved for nmCRPC in the US, and around three months after Astellas and Pfizer picked up EU approval for their androgen ... Xtandi has also been approved for nmCRPC in the US, so the two drugs

  • FDA expecting boom in cell and gene therapies FDA expecting boom in cell and gene therapies

    by the US government shutdown, now in its fourth week. ... The last couple of years have already seen the approval of the first gene therapy in the US – Spark Therapeutics’ Luxturna for a rare disease – as well as new cell therapies

  • China approves Ironwood Pharma’s IBS treatment China approves Ironwood Pharma’s IBS treatment

    Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion. Ironwood and Allergan (its US marketing partner) have also just secured a vital Linzess patent settlement with generic challenger Mylan. ... This grants US market exclusivity for the firms until.

  • FDA moves into crisis mode as shutdown drags on FDA moves into crisis mode as shutdown drags on

    New drug appraisals already being affected. As the US government shutdown enters a record fourth week, FDA Commissioner Scott Gottlieb says the agency is now facing one of the most significant

More from news
Approximately 150 fully matching, plus 5,246 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 549 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 742 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 14 fully matching, plus 808 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics